There was a trend of decreased time to composite event in patients aged>40 years relative to those aged ≤40 years, but this did not reach statistical significance ( online supplemental figure S2A ; p=0.06).
← all excerpts
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes.
1
0.0600
0.0600